2024-03-28T19:54:56Z
https://u-ryukyu.repo.nii.ac.jp/oai
oai:u-ryukyu.repo.nii.ac.jp:02016008
2022-10-31T07:48:34Z
1642838163960:1642838198944:1642838199408:1642838204224
1642838403551:1642838412624
[原著]病理病期I期非小細胞肺癌症例の臨床的検討
Clinical Studies on Pathological Stage I Non-Small-Cell Lung Cancer
川畑, 勉
城間, 寛
鎌田, 義彦
佐久田, 斉
玉木, 正人
久貝, 忠男
下地, 光好
宮城, 和史
赤崎, 満
伊波, 潔
国吉, 幸男
古謝, 景春
草場, 昭
中村, 浩明
斎藤, 厚
Kawabata, Tsutomu
Shiroma, Hiroshi
Kamada, Yoshihiko
Sakuda, Hitoshi
Tamaki, Masato
Kugai, Tadao
Shimoji, Mitsuyoshi
Miyagi, Kazufumi
Akasaki, Mitsuru
Iha, Kiyoshi
Kuniyoshi, Yukio
Koja, Kageharu
Kusaba, Akira
Nakamura, Hiroaki
Saito, Atsushi
stage I lung cancer
curative resection
prognostic factor
We encountered 25 cases of pathological stage I non-small-cell lung cancer with curative resection-from January 1984 till July 1993. The cumalative 5-year survival rate was 67.2%. The clinical prognostic factors which influence the postoperative survival were studied. The factors analysed were as follows: (1) sex(male and female) ; (2) age (under and over 70 years old) ; (3) histological type(adenocarcinoma and squamous cell carcinoma) ; (4) T factor(Tl and T2) ; (5)Tumor markers(present or absent) ; (6)smoking habit(smorker and nonsmoker) ; (7) adjuvant chemotherapy (recipients and nonrecipients) ; (8) symptom (symptomatic and asymptomatic). These factors had no influence on survival. Even though tumor marker was positive or T factor was T2, there was no significant difference on the survival when curative resection was carried out in stage I non-small-cell lung cancer.
論文
http://purl.org/coar/resource_type/c_6501
琉球医学会
Ryukyu Medical Association
1994
VoR
1346888X
0289-1530
AN10369445
琉球医学会誌 = Ryukyu Medical Journal
2
14
149
145
jpn
open access
琉球医学会